Point72 Asia (Singapore)’s Ginkgo Bioworks DNA Stock Holding History

Point72 Asia (Singapore)’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-56,078	Closed	-$320K	–	974
2025 Q1	$320K	Buy	56,078 +31,260	+126%	+$318K	0.08%	191
2024 Q4	$244K	Sell	24,818 -7,501	-23%	-$64.3K	0.06%	216
2024 Q3	$263K	Buy	32,319 +32,210	+29,550%	+$323K	0.05%	311
2024 Q2	$1.45K	Sell	109 -761	-87%	-$22.7K	﹤0.01%	997
2024 Q1	$40.4K	Buy	+870	New	+$45K	0.01%	838

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asia (Singapore)'s DNA Position: Q2 2025 in Review

Point72 Asia (Singapore) sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 56,078 shares — an estimated $320K sold.

Point72 Asia (Singapore) first reported a position in DNA in Q1 2024 and held it in 5 quarters. The position peaked at $320K in Q1 2025. 166 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

Point72 Asia (Singapore) reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
Point72 Asia (Singapore) sold 56,078 Ginkgo Bioworks shares in Q2 2025, an estimated $320K.
Point72 Asia (Singapore) first reported a position in Ginkgo Bioworks in Q1 2024 and held it in 5 quarters.
Point72 Asia (Singapore)'s Ginkgo Bioworks position peaked at $320K in Q1 2025.
166 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.